1 Min Read
Feb 15 (Reuters) - Dova Pharmaceuticals Inc:
* DOVA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 OPERATING AND FINANCIAL RESULTS
* DOVA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.36 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.